Maaike de Bie

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells

Jeltje F. de Vries, C. Michel Zwaan, Maaike de Bie et al. · Leukemia · 2011 · 114 citations

Hematological Malignancy, Medicine, Immunology +7

Vδ2-Jα rearrangements are frequent in precursor-B–acute lymphoblastic leukemia but rare in normal lymphoid cells

Tomasz Szczepański, Vincent H. J. van der Velden, Patricia G. Hoogeveen et al. · Blood · 2003 · 73 citations · Full text

TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse

Vincent H. J. van der Velden, Monika Brüggemann, Patricia G. Hoogeveen et al. · Leukemia · 2004 · 66 citations

Genetic Disorder, Medicine, Genetics +8

New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B‐cell precursor acute lymphoblastic leukaemia

Vincent H. J. van der Velden, Daphne de Launaij, Jeltje F. de Vries et al. · British Journal of Haematology · 2015 · 57 citations

Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity

Julia C. Berentschot, Hemmo A. Drexhage, Daniel G. Aynekulu Mersha et al. · Frontiers in Immunology · 2023 · 51 citations · Full text